JTD Reading Tools
How to cite item
Outcomes from salvage chemotherapy or pembrolizumab beyond progression with or without local ablative therapies for advanced non-small cell lung cancers with PD-L1 ≥50% who progress on first-line immunotherapy: real-world data from a European cohort
Citation Format
ABNT
APA
BibTeX
CBE
EndNote - EndNote format (Macintosh & Windows)
MLA
ProCite - RIS format (Macintosh & Windows)
RefWorks
Reference Manager - RIS format (Windows only)
Turabian
@article{{JTD}{34322}, author = {Metro, G., Addeo, A., Signorelli, D., Gili, A., Economopoulou, P., Roila, F., Banna, G., Toma, A., Cobo, J., Camerini, A., Christopoulou, A., Russo, G., Banini, M., Galetta, D., Jimenez, B., Collazo-Lorduy, A., Calles, A., Baxevanos, P., Linardou, H., Kosmidis, P., Garassino, M., Mountzios, G.}, title = {Outcomes from salvage chemotherapy or pembrolizumab beyond progression with or without local ablative therapies for advanced non-small cell lung cancers with PD-L1 ≥50% who progress on first-line immunotherapy: real-world data from a European cohort}, journal = {Journal of Thoracic Disease}, volume = {11}, number = {12}, year = {2019}, url = {https://jtd.amegroups.org/article/view/34322} }